SCHEMBL4497264

SCHEMBL4497264

COc1ccc(-c2sc(CNS(=O)(=O)c3cccc(C(F)(F)F)c3)cc2-c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
MAPT P10636 3/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
ALOX15 P16050 1/20 0.44
SLC20A2 Q08357 1/20 0.43
SLC20A1 Q8WUM9 1/20 0.43
IDH2 P48735 1/20 0.40
KDM1A O60341 2/20 0.40
PLAU P00749 1/20 0.40
PLAT P00750 1/20 0.40
PKM P14618 1/20 0.39
KMT2A Q03164 1/20 0.39
PPARG P37231 1/20 0.39
PGR P06401 1/20 0.39
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505757 0.90 PGR (0.48) ALDH1A1MAPTKDM4EGAAL3MBTL1
SCHEMBL4491425 0.89 FLT1 (0.47) ALDH1A1MAPTGAAL3MBTL1TDP1
SCHEMBL4490302 0.89 ALDH1A1 (0.41) ALDH1A1MAPTKDM4EGAAL3MBTL1
SCHEMBL4508036 0.86 KDM1A (0.46) ALDH1A1MAPTKDM4EKDM1APPARG
SCHEMBL4494987 0.86 ALDH1A1 (0.47) ALDH1A1MAPTGAATDP1KDM1A
SCHEMBL4492694 0.85 MAPT (0.41) ALDH1A1MAPTKDM4ETDP1KMT2A
SCHEMBL4507017 0.85 ALDH1A1 (0.41) ALDH1A1MAPTKDM4EGAAL3MBTL1
SCHEMBL4499994 0.84 GSR (0.45) ALDH1A1MAPTKDM4ETDP1PLAU
SCHEMBL4506429 0.84 ALDH1A1 (0.43) ALDH1A1MAPTGAATDP1KMT2A
SCHEMBL4488977 0.84 MAPT (0.42) ALDH1A1MAPTKDM4EGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589120-B2 N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application SANOFI-AVENTIS (FR) 2009-09-15 US claimed
US-20070287744-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]SULFONAMIDE DERIVATIVES, PREPARATION THEREOF AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-12-13 US claimed
EP-1841754-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]SULFONAMIDE DERIVATIVES, PREPARATION THEREOF AND THEIR THERAPEUTIC APPLICATION Sanofi-Aventis (FR) 2007-10-10 EP claimed
WO-2006077320-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]SULFONAMIDE DERIVATIVES, PREPARATION THEREOF AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2006-07-27 WO claimed
US-7589120-B2 N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application SANOFI-AVENTIS (FR) 2009-09-15 US disclosed
US-20070287744-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]SULFONAMIDE DERIVATIVES, PREPARATION THEREOF AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287744-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]SULFONAMIDE DERIVATIVES, PREPARATION THEREOF AND THEIR THERAPEUTIC APPLICATION TPMT, TXNRD2, ARG2 ALDH1A1 385/4885MAPT 4238/4885KDM4E 748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.